SuperworthClearPoint Neuro shares outstanding CLPT
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 30.2M
- On a year earlier
- +6.8%
- more shares
ClearPoint Neuro had 30.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 6.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 28.8M | +5% |
| FY2024 | 27.6M | +12% |
| FY2023 | 24.6M | +0% |
| FY2022 | 24.5M | +15% |
| FY2021 | 21.3M | +27% |
| FY2020 | 16.7M | +10% |
| FY2019 | 15.2M | +38% |
| FY2018 | 11M | +4% |
| FY2017 | 10.6M | +193% |
| FY2016 | 3.6M | +88% |
| FY2015 | 1.9M | +27% |
| FY2014 | 1.5M | +3% |
| FY2013 | 1.5M | +22% |
| FY2012 | 1.2M | +199% |
| FY2011 | 402.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 30.2M | +7% | |
| Q1 FY26 | 29.5M | +7% | |
| Q4 FY25 | 28.8M | +5% | |
| Q3 FY25 | 28.4M | +3% | |
| Q2 FY25 | 28.3M | +3% | |
| Q1 FY25 | 27.7M | +9% | |
| Q4 FY24 | 27.6M | +12% | |
| Q3 FY24 | 27.6M | +12% | |
| Q2 FY24 | 27.5M | +12% | |
| Q1 FY24 | 25.5M | +4% | |
| Q4 FY23 | 24.6M | +0% | |
| Q3 FY23 | 24.6M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on ClearPoint Neuro
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.